Immunotherapy for Colon Cancer Treatment
If you or a loved one has been diagnosed with colon cancer, identifying the treatment approach that’s best for you and your particular circumstances is
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Colon cancer, which affects more than 100,000 new patients each year in the United States, begins as a growth called a polyp. It originates in the innermost lining of the colon and grows outward, having the potential to eventually affect the blood vessels, lymph nodes and other areas of the body. As the third most commonly diagnosed cancer in the country, there are several types of colon polyps and cancers, all of which can be treated by Regional Cancer Care Associates. Here’s a look at each.
Commonly known as adenomas or adenocarcinomas, adenomatous polyps are most commonly found in colon cancer patients and account for roughly 70 percent of all types of colon polyps. These polyps are considered precancerous, although it can take years for colon cancer to develop. Unlike other polyps, adenomas are a result of neoplasia, which is when a new, abnormal growth of neoplastic cells takes on different characteristics compared with normal cells. These cells then group into a tumor called a neoplasm, and when the tumor is malignant, colon cancer is present.
Though all adenomas are precancerous to start, a subtype of adenomatous polyps, known as villous adenoma, carries a greater risk of becoming cancerous compared with other subtypes. An estimated 30 percent of all villous adenomas found in the colon’s lining will develop into colon cancer. If an adenomatous polyp has a broccoli-like appearance, it is identified as a villous adenoma.
Other types of colon polyps are not considered precancerous and typically are found to be benign. However, these types of polyps do sometimes, though rarely, develop into colon cancer and should not be ignored. One of these types is hyperplastic polyps, which get their name from hyperplasia, a condition in which normal cells increase at an abnormal rate and form an enlarged polyp. Though these grow very quickly, they carry a low risk of developing into colon cancer.
Inflammatory polyps have a slightly deceiving name. Also known as pseudopolyps or false polyps, they are a small area of foci, or abnormal cells, that become inflamed because of a reaction the colon is having to another condition. For instance, persons with inflammatory bowel disease, ulcerative colitis or Crohn’s disease are more likely to experience inflammatory polyps. Though they are unlikely to develop into malignant tumors, they still should be monitored carefully by your doctor.
While about 70 percent of colon cancers involve adenomas, some colon cancers result from other abnormalities that do not involve polyps. Rarer types of colon cancer tumors include:
Regardless of which type of colon polyps or cancer you or a loved one may have, Regional Cancer Care Associates offers the highly specialized care necessary to restore your health. With numerous locations across New Jersey, Maryland and Connecticut, state-of-the-art treatments and the latest research-based methods are just a phone call away. To learn more, schedule an appointment at one of our locations or contact Regional Cancer Care Associates today at 844-346-7222.
If you or a loved one has been diagnosed with colon cancer, identifying the treatment approach that’s best for you and your particular circumstances is
Some symptoms of colon cancer may not be easy to diagnose. Read about the more uncommon symptoms on Regional Cancer Care Associates’ online blog.
Colon cancer continues to be one of the most common cancer types diagnosed in men and women in the United States. The American Cancer Society
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.